CAM
WST icon

Congress Asset Management’s West Pharmaceutical WST Stock Holding History

Congress Asset Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,380
Closed -$362K – 405
2025
Q3 		$362K Buy
+1,380
New +$335K ﹤0.01% 369
2025
Q2 		– Sell
-253,252
Closed -$56.7M – 404
2025
Q1 		$56.7M Sell
253,252
-35,796
-12% -$9.87M 0.42% 94
2024
Q4 		$94.7M Sell
289,048
-28,421
-9% -$8.94M 0.64% 69
2024
Q3 		$95.3M Sell
317,469
-7,918
-2% -$2.42M 0.65% 70
2024
Q2 		$107M Sell
325,387
-2,745
-0.8% -$970K 0.77% 59
2024
Q1 		$130M Sell
328,132
-308
-0.1% -$114K 0.93% 39
2023
Q4 		$116M Sell
328,440
-12,799
-4% -$4.53M 0.91% 44
2023
Q3 		$128M Sell
341,239
-1,920
-0.6% -$743K 1.13% 16
2023
Q2 		$131M Sell
343,159
-7,748
-2% -$2.77M 1.14% 16
2023
Q1 		$122M Sell
350,907
-23,598
-6% -$6.9M 1.13% 26
2022
Q4 		$88.1M Buy
374,505
+16,204
+5% +$3.84M 0.88% 54
2022
Q3 		$88.2M Buy
358,301
+20,300
+6% +$6.18M 0.95% 48
2022
Q2 		$102M Sell
338,001
-14,601
-4% -$4.75M 0.98% 39
2022
Q1 		$145M Sell
352,602
-12,825
-4% -$5.02M 1.23% 18
2021
Q4 		$171M Sell
365,427
-22,476
-6% -$9.67M 1.31% 19
2021
Q3 		$165M Sell
387,903
-6,712
-2% -$2.83M 1.29% 15
2021
Q2 		$142M Sell
394,615
-7,709
-2% -$2.55M 1.19% 28
2021
Q1 		$113M Sell
402,324
-12,220
-3% -$3.5M 1.02% 43
2020
Q4 		$117M Buy
414,544
+1,530
+0.4% +$429K 1.11% 34
2020
Q3 		$114M Sell
413,014
-1,040
-0.3% -$275K 1.23% 27
2020
Q2 		$94.1M Buy
414,054
+408,683
+7,609% +$80.3M 1.12% 37
2020
Q1 		$818K Buy
5,371
+27
+0.5% +$4.16K 0.01% 262
2019
Q4 		$803K Sell
5,344
-325
-6% -$47.3K 0.01% 289
2019
Q3 		$804K Buy
+5,669
New +$781K 0.01% 295
2018
Q2 		– Sell
-2,852
Closed -$252K – 384
2018
Q1 		$252K Buy
+2,852
New +$267K ﹤0.01% 369

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Congress Asset Management's WST Position: Q4 2025 in Review

Congress Asset Management sold out of West Pharmaceutical (WST) in Q4 2025, closing a stake of 1,380 shares — an estimated $362K sold.

Congress Asset Management first reported a position in WST in Q1 2018 and held it in 25 quarters. The position peaked at $171M in Q4 2021. 802 funds tracked by Wall St. Rank hold WST as of Q4 2025.

  • Congress Asset Management reported no remaining West Pharmaceutical position as of Q4 2025 after selling out during the quarter.
  • Congress Asset Management sold 1,380 West Pharmaceutical shares in Q4 2025, an estimated $362K.
  • Congress Asset Management first reported a position in West Pharmaceutical in Q1 2018 and held it in 25 quarters.
  • Congress Asset Management's West Pharmaceutical position peaked at $171M in Q4 2021.
  • 802 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2025.

Based on Congress Asset Management's 13F filing for Q4 2025, filed 9 Jan 2026.